Remove Bioinformatics Remove DNA Remove Information
article thumbnail

Genomic score predicts patients' progression to multiple myeloma

Broad Institute

In the future, the MM-like score could be used in clinical practice to inform decisions about early intervention. This study brings us closer to more personalized care for patients with a precursor stage of cancer and could better inform early intervention strategies in the future. The study was published in Nature Genetics.

DNA 52
article thumbnail

Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration

The Pharma Data

By leveraging our unique ability to manufacture DNA at scale, we can construct proprietary antibody libraries precisely designed to match sequences that occur in the human body. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip.

DNA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A scientist devotes her career to tackling inequity in genomics

Broad Institute

At the Broad, Martin is also helping lead data analysis in two large international studies that are sequencing the DNA of people from Africa and Latin America to learn about the genetics of severe mental illness. Alicia Martin and attendees of the KEMRI-Wellcome Trust/GINGER Bioinformatics training in Kilifi, Kenya in September 2018.

article thumbnail

Next Generation Sequencing (NGS): why is quantifying nucleic acids important? | BMG LABTECH

BMG Labtech

These numbers reflect impressive developments in DNA sequencing technologies but in most cases represent the immediate costs of consumables on the sequencing instrument. 2 DNA sequencing is also reliant on sample processing and DNA library preparation before sequencing as well as bioinformatics and data analysis after sequencing.

DNA 52
article thumbnail

United Therapeutics Releases Its First Corporate Responsibility Report

The Pharma Data

24, 2020 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR) today announced the release of its initial Corporate Responsibility Report with primarily 2019 data and selected 2020 highlights, providing stakeholders important information regarding the company’s commitment to environmental, social, and governance (ESG) priorities.

article thumbnail

Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board

The Pharma Data

Diversigen provides consultative end-to-end solutions for sequencing, bioinformatics, and statistical analysis for the study of the microbiome of living organisms and environments. For more information, visit www.diversigen.com or contact info@diversigen.com. For more information, visit www.orasure.com. Diversigen, Inc.

article thumbnail

Molecular map reveals insights into the genetic drivers of chronic lymphocytic leukemia

Broad Institute

To build the CLL map, the team analyzed variations in genetic sequences, gene expression patterns, and chemical modifications to DNA — or genomic, transcriptomic, and epigenomic data — from 1,148 patients.